L. Fiore

G. Saggese, L. Gagliardi, R. Liguori, 2005, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Suppression of Fas Expression and Down-Regulation of Fas Ligand in Highly Aggressive Human Thyroid Carcinoma

G. Fontanini, F. Basolo, R. Danesi, 2000, Laboratory Investigation.

Normal breast epithelial cells produce interleukins 6 and 8 together with tumor‐necrosis factor: Defective il6 expression in mammary carcinoma

F. Basolo, A. Toniolo, P. Conaldi, 1993, International journal of cancer.

Pubertal Changes in Biochemical Markers of Growth

G. Saggese, G. Baroncelli, G. Federico, 2003, Hormone Research in Paediatrics.

Regulation of surface‐differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c‐Ha‐ras proto‐oncogene

J. Russo, F. Ciardiello, F. Basolo, 1992, International journal of cancer.

Evaluation of brain-derived neurotrophic factor in menstrual blood and its identification in human endometrium

A. Genazzani, N. Pluchino, S. Luisi, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.

G. Merlo, G. Fontanini, F. Basolo, 1996, British Journal of Cancer.

p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin

F. Basolo, N. Hynes, L. Fiore, 1995, The Journal of cell biology.

Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies.

G. Fontanini, F. Basolo, A. Toniolo, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

No evidence of chromosome damage in children and adolescents with differentiated thyroid carcinoma after receiving 131I radiometabolic therapy, as evaluated by micronucleus assay and microarray analysis

G. Mariani, G. Saggese, R. Scarpato, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

NM23 gene expression correlates with cell growth rate and S‐phase

F. Ciardiello, G. Bevilacqua, F. Basolo, 1995, International journal of cancer.

Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: The impact on bone mass

G. Saggese, G. Baroncelli, G. Federico, 2004, Journal of endocrinological investigation.

Production of Cytokines and Response to Them in Normal and Transformed Human Mammary Epithelial Cells a

F. Basolo, A. Toniolo, C. Serra, 1993, Annals of the New York Academy of Sciences.

Potentiation of the malignant phenotype of the undifferentiated ARO thyroid cell line by insertion of the bcl‐2 gene

G. Merlo, G. Fontanini, A. Fusco, 1999, International journal of cancer.

The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: Results from a controlled study

G. Saggese, G. Federico, S. Barsanti, 2001 .

Licoflavone C attenuates the genotoxicity of cancer drugs in human peripheral lymphocytes

R. Scarpato, G. Federico, L. Fiore, 2008, Phytotherapy research : PTR.

Expression of and Response to lnie rleukin 6 (IL6) in Human Mammary Tumors1

Gabriella, P. Conaldi, L. Fiore, 2006 .